CHC
GSK icon

City Holding Co’s GSK GSK Stock Holding History

City Holding Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Hold
550
– – ﹤0.01% 405
2026
Q1 		$30.3K Hold
550
– – ﹤0.01% 378
2025
Q4 		$27K Sell
550
-800
-59% -$37.3K ﹤0.01% 396
2025
Q3 		$58.3K Buy
1,350
+800
+145% +$31.2K 0.01% 332
2025
Q2 		$21.1K Hold
550
– – ﹤0.01% 379
2025
Q1 		$21.3K Buy
+550
New +$20.1K ﹤0.01% 403
2024
Q3 		– Sell
-2,484
Closed -$95.6K – 464
2024
Q2 		$95.6K Sell
2,484
-984
-28% -$41.4K 0.01% 263
2024
Q1 		$149K Sell
3,468
-80
-2% -$3.3K 0.02% 250
2023
Q4 		$131K Sell
3,548
-1,020
-22% -$36.6K 0.02% 251
2023
Q3 		$166K Sell
4,568
-119
-3% -$4.22K 0.03% 237
2023
Q2 		$167K Sell
4,687
-232
-5% -$8.32K 0.03% 241
2023
Q1 		$175K Hold
4,919
– – 0.03% 235
2022
Q4 		$173K Sell
4,919
-331
-6% -$11K 0.03% 232
2022
Q3 		$154K Sell
5,250
-264
-5% -$10K 0.03% 232
2022
Q2 		$300K Sell
5,514
-100
-2% -$5.52K 0.06% 188
2022
Q1 		$306K Sell
5,614
-24
-0.4% -$1.3K 0.05% 194
2021
Q4 		$295K Sell
5,638
-770
-12% -$40.1K 0.05% 196
2021
Q3 		$306K Sell
6,408
-1,864
-23% -$93.6K 0.05% 194
2021
Q2 		$412K Sell
8,272
-352
-4% -$16.9K 0.07% 172
2021
Q1 		$385K Sell
8,624
-24,034
-74% -$1.09M 0.07% 161
2020
Q4 		$1.5M Sell
32,658
-15,048
-32% -$691K 0.31% 94
2020
Q3 		$2.24M Buy
47,706
+560
+1% +$28.1K 0.51% 68
2020
Q2 		$2.4M Sell
47,146
-52
-0.1% -$2.67K 0.6% 56
2020
Q1 		$2.23M Buy
47,198
+40
+0.1% +$2.13K 0.67% 52
2019
Q4 		$2.77M Buy
47,158
+1,732
+4% +$96.3K 0.66% 52
2019
Q3 		$2.42M Sell
45,426
-284
-0.6% -$14.6K 0.63% 59
2019
Q2 		$2.29M Buy
45,710
+1,807
+4% +$90.7K 0.62% 59
2019
Q1 		$2.29M Buy
43,903
+3,793
+9% +$190K 0.65% 55
2018
Q4 		$1.92M Buy
40,110
+2,005
+5% +$98.7K 0.63% 59
2018
Q3 		$1.91M Sell
38,105
-214
-0.6% -$10.9K 0.55% 69
2018
Q2 		$1.93M Sell
38,319
-303
-0.8% -$15.3K 0.59% 63
2018
Q1 		$1.89M Buy
38,622
+1,327
+4% +$61.8K 0.6% 61
2017
Q4 		$1.65M Buy
37,295
+89
+0.2% +$4.11K 0.52% 73
2017
Q3 		$1.89M Buy
37,206
+932
+3% +$47.3K 0.63% 56
2017
Q2 		$1.96M Buy
36,274
+4,076
+13% +$217K 0.69% 51
2017
Q1 		$1.7M Buy
32,198
+1,178
+4% +$59.8K 0.64% 54
2016
Q4 		$1.49M Buy
31,020
+4,000
+15% +$198K 0.58% 59
2016
Q3 		$1.46M Sell
27,020
-416
-2% -$22.8K 0.63% 55
2016
Q2 		$1.49M Buy
27,436
+2,198
+9% +$116K 0.66% 51
2016
Q1 		$1.28M Sell
25,238
-240
-0.9% -$12K 0.64% 56
2015
Q4 		$1.28M Sell
25,478
-908
-3% -$46.3K 0.66% 54
2015
Q3 		$1.27M Buy
26,386
+20
+0.1% +$1.04K 0.69% 50
2015
Q2 		$1.37M Buy
26,366
+1,420
+6% +$80K 0.7% 54
2015
Q1 		$1.44M Buy
24,946
+1,753
+8% +$100K 0.73% 49
2014
Q4 		$1.24M Buy
23,193
+2,698
+13% +$151K 0.65% 58
2014
Q3 		$1.18M Buy
20,495
+869
+4% +$53.3K 0.65% 57
2014
Q2 		$1.19M Sell
19,626
-129
-0.7% -$8.73K 0.68% 53
2014
Q1 		$1.32M Buy
19,755
+520
+3% +$35.2K 0.8% 42
2013
Q4 		$1.28M Buy
+19,235
New +$1.25M 0.81% 39

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

City Holding Co's GSK Position: Q2 2026 in Review

City Holding Co held its GSK (GSK) position steady in Q2 2026 at 550 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

City Holding Co first reported a position in GSK in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.77M in Q4 2019. 218 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • City Holding Co held 550 shares of GSK worth $28.8K as of Q2 2026.
  • City Holding Co left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of City Holding Co's portfolio in Q2 2026, its #405 holding.
  • City Holding Co first reported a position in GSK in Q4 2013 and has held it in 49 quarters since.
  • City Holding Co's GSK position peaked at $2.77M in Q4 2019.
  • 218 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.